Concourse Financial Group Securities’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-221
| Closed | -$25.7K | – | 7297 |
|
|
2024
Q4 | $25.7K | Sell |
221
-12
| -5% | -$1.39K | ﹤0.01% | 1469 |
|
|
2024
Q3 | $29.1K | Sell |
233
-8
| -3% | -$999 | ﹤0.01% | 1401 |
|
|
2024
Q2 | $38.1K | Buy |
241
+12
| +5% | +$1.9K | ﹤0.01% | 1294 |
|
|
2024
Q1 | $29.6K | Buy |
229
+6
| +3% | +$777 | ﹤0.01% | 1388 |
|
|
2023
Q4 | $21.5K | Hold |
223
| – | – | ﹤0.01% | 1466 |
|
|
2023
Q3 | $27K | Buy |
223
+157
| +238% | +$19K | ﹤0.01% | 1339 |
|
|
2023
Q2 | $7.56K | Hold |
66
| – | – | ﹤0.01% | 1730 |
|
|
2023
Q1 | $9.1K | Buy |
+66
| New | +$9.1K | ﹤0.01% | 1685 |
|
|
2022
Q4 | – | Sell |
-66
| Closed | -$7K | – | 7064 |
|
|
2022
Q3 | $7K | Hold |
66
| – | – | ﹤0.01% | 1578 |
|
|
2022
Q2 | $5K | Hold |
66
| – | – | ﹤0.01% | 1858 |
|
|
2022
Q1 | $5K | Sell |
66
-1,476
| -96% | -$112K | ﹤0.01% | 1870 |
|
|
2021
Q4 | $139K | Sell |
1,542
-100
| -6% | -$9.01K | 0.01% | 861 |
|
|
2021
Q3 | $152K | Sell |
1,642
-60
| -4% | -$5.55K | 0.01% | 821 |
|
|
2021
Q2 | $132K | Buy |
1,702
+60
| +4% | +$4.65K | 0.01% | 864 |
|
|
2021
Q1 | $122K | Sell |
1,642
-55
| -3% | -$4.09K | 0.01% | 852 |
|
|
2020
Q4 | $289K | Buy |
1,697
+8
| +0.5% | +$1.36K | 0.02% | 504 |
|
|
2020
Q3 | $237K | Buy |
1,689
+247
| +17% | +$34.7K | 0.02% | 498 |
|
|
2020
Q2 | $231K | Hold |
1,442
| – | – | 0.02% | 467 |
|
|
2020
Q1 | $141K | Buy |
1,442
+800
| +125% | +$78.2K | 0.02% | 558 |
|
|
2019
Q4 | $83K | Hold |
642
| – | – | 0.01% | 768 |
|
|
2019
Q3 | $48K | Sell |
642
-31
| -5% | -$2.32K | 0.01% | 635 |
|
|
2019
Q2 | $102K | Buy |
673
+553
| +461% | +$83.8K | 0.01% | 652 |
|
|
2019
Q1 | $14K | Buy |
+120
| New | +$14K | ﹤0.01% | 1403 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5013 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4827 |
|